← Open Payments lookup

COREY FINCH: Open Payments

NPI 1407903644 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$596 in 19 payments from 12 companies in 2025. Trend: 2023 $992 · 2024 $435 · 2025 $596

Food & beverage: $498Education: $98
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.7$196
Neurocrine BioSciences, Inc.1$136
Acarix USA Inc.1$44
PFIZER INC.2$39
Otsuka America Pharmaceutical, Inc.1$34
Corcept Therapeutics1$31
SK Life Science, Inc.1$24
UCB, Inc.1$22
E.R. Squibb & Sons, L.L.C.1$19
Salix Pharmaceuticals, a division of Bausch Health US, LLC1$18

Products named: INGREZZA, AUSTEDO XR, REXULTI, CADScor System, NURTEC ODT, Korlym, Briviact, COBENFY.

Industry payments across OK — which companies pay providers there.